Primary Chest Wall Ewing Sarcoma: Treatment and Long-Term Results

• Published in: Life (Basel, Switzerland) Vol. 14; no. 6; p. 766
• Main Authors: Salimbene, Ottavia, Viggiano, Domenico, Muratori, Francesco, Lo Piccolo, Roberto, Facchini, Flavio, Tamburini, Angela, Campanacci, Domenico Andrea, Voltolini, Luca, Gonfiotti, Alessandro
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01.06.2024; MDPI
• Subjects: Biopsy; Cancer therapies; Care and treatment; Case Report; Chemotherapy; Chest; chest wall reconstruction; Classification; Complications; Diagnosis; Diaphragm (Anatomy); Ewing sarcoma; Ewing's sarcoma; Ewings sarcoma; Medical records; Metastases; Mortality; multidisciplinary approach; Muscles; Orthopedics; Patient outcomes; Patients; Pediatric research; Pediatrics; Postoperative; Prostheses; Radiation therapy; Rib; Sarcoma; Surgeons; Surgery; Survival; Thoracic cancer; Tomography; Tumors; Italy; United States > US
• ISSN: 2075-1729; 2075-1729
• DOI: 10.3390/life14060766

Objective: The aim of the study is to evaluate early and long-term results of chest wall primary Ewing’s sarcoma patients treated in the time period February 2000–February 2023 by a multidisciplinary approach. Methods: We retrospectively reviewed the medical records of patients who underwent chest wall resection for a primary tumor. Treatment approach, extent of resection, 30-day mortality, overall survival (OS), local recurrence-free survival (LRFS), and metastasis-free survival (MFS) were analyzed. Results: Overall, n = 15 consecutive patients were treated for chest wall primary Ewing’s sarcoma. A median of n = 3 ribs was resected with a median of n = 2 ribs adjacent to the lesion. Resections were extended to the adjacent structures in n = 5 patients (33.3%). In all cases, we performed a prosthetic reconstruction, associated with muscle flap (n = 10, 66.6%) or with rigid titanium bars and muscle flap (n = 6, 40%). A radical resection was accomplished in n = 13 patients (84.6%). The median surgical time was 310 ± 120 min; median hospitalization was 7.8 ± 1.9 days. Post-operative mortality was zero. We recorded n = 4 (30.7%) post-operative complication. The median follow-up (FU) was 26 months. Moreover, 5-year overall and event-free survival were 52% and 48%, respectively. Conclusions: This case series confirms the benefit of the multidisciplinary approach for Ewing sarcomas in early and long-term results.